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Supplementary Figure 1, related to Figures 1 and 2: Comparison of bi- and multinucleation 
during the MGC transformation process 




 cells (grey, dashed) and MC (light blue) 
were stimulated with BCG (MOI 20 or 100) for 2, 4 and 6 days. Quantification of MGC by 
Hemacolor staining. Depicted are mean ± SEM of n=3-7 biologically independent samples. 
Detailed sample numbers (n) for each condition are presented in Supplementary Table 6. 
***p=0.001 (cMoP – MDP), ****p< 0.0001 (cMoP – MDP), ##p=0.0049 (MDP – Lin- c-kit+), 
##
p=0.0024 (MDP – MC), ####p< 0.0001 (refers to MC and Lin- c-kit+); (two-way ANOVA, 
Tukey’s multiple comparisons test (MCT)). 
b Representative Hemacolor stainings of cMoP from Cx3cr1
gfp/+
 mice stimulated with BCG 
(MOI  20) for 2 (n=5 independent stainings) and 6 days (n=7 independent stainings). Scale bar: 
100 µm. 
c cMoP (dark blue) and MC (light blue) were stimulated with BCG (MOI 20) or heat-fixed (hf) 
BCG (10
6
/ml) for 6 days. Analysis of MGC formation and binucleated cells after Hemacolor 
staining. Graphs show mean ± SEM of n=10 (BCG MOI 20) and n=11 (BCG hf) biologically 
independent samples in 4 experiments. ns= not significant (BCG hf: p=0.0945 and BCG MOI 20: 
p=0.1127), *p=0.0179 (BCG hf), *p=0.0467 (BCG MOI 20), ****p< 0.0001 (student´s unpaired 
t-test, two-tailed). 
d Formation of binucleated cells of cMoP and MC from Cx3cr1
gfp/+
 mice stimulated with BCG 
(MOI 20) or hf BCG (10
6
/ml) for 6 days compared to M-CSF (50 ng/ml) control. Bars show 
mean ± SEM of n=13 (-), n=10 (BCG MOI 20), n=11 (BCG hf) biologically independent samples 
in 4 experiments. **p=0.0015 (MC), **p=0.0017 (cMoP), ****p< 0.0001 (one-way ANOVA, 
Dunnett’s MCT).  
e Representative Hemacolor stainings of MDP (n=4 independent stainings) and MC (n=6 
independent stainings) from Cx3cr1
gfp/+
 mice stimulated with LM (4 µg/ml) for 6 days. Scale bar: 
100 µm. 




 blood monocytes (n=2 independent 
stainings) stimulated with LM (4 µg/ml) for 6 days. Scale bar: 100 µm. 
g Quantification of mitochondrial membrane potential (ΔΨm) by FACS in cMoP and MC 
stimulated with hf BCG (10
6
/ml) compared to control cells (-) after 6 days. Bars show mean ± 
SEM of n=4 independent biological samples examined over 2 experiments. ***p=0.0009 (cMoP-













































































































































































































































































































































































































































































































Supplementary Figure 2, related to Figure 3: Further analysis of gene expression patterns 
in cMoP and MC after stimulation with mycobacterial glycolipids 
a and b cMoP and MC from Cx3cr1
gfp/+
 mice were harvested after 4, 8, 12 or 48 hours in culture 
with M-CSF (50 ng/ml) alone (a) or after additional stimulation with LM (4 µg/ml) (b) and 
analyzed for surface marker expression related to CD45
+
 cells by FACS.  Depicted are mean ± 
SEM of n=3-9 biologically independent samples. Detailed sample numbers (n) for each condition 
are presented in Supplementary Table 4. *p=0.0142, **p=0.0085 (CD115), **p=0.0054 
(CD117), ***p=0.0007, ****p< 0.0001 (two-way ANOVA, Sidak’s MCT).  
c and d Principal component analysis for all samples (c) and cultivated and differentiated 
samples only (d). Plotted are loadings for principal components PC1 and PC2. 
e Heatmap of gene expression in cMoP and MC from Cx3cr1
gfp/+
 mice stimulated with LM 
(4 µg/ml) for 48 hours. Depicted are standardized log2 differences of significantly up- (red) or 
downregulated (blue) genes in cMoP LM compared to MC LM or cMoP (-) compared to MC (-). 
Analysis was performed by GO-Term (GO:0006629 lipid metabolic process). If GO-Terms 
overlap with genes shown in heatmaps in Fig. 3d respective genes are not depicted here again. 
Gene array was performed with 2 independent biological samples per group (1 = samples 1; 
2 = sample 2). 
f Bars show mean of Mki67 expression for cMoP and MC stimulated with LM (4 µg/ml, light 
grey, diamonds) compared to M-CSF (50 ng/ml) controls (dark grey, triangles) from gene array 
analysis with n=2 independent biological samples per group.  
g qRT-PCR analysis of Tlr2 and proIL-1β mRNA relative to Gapdh mRNA in cMoP and MC 
stimulated with LM (12 µg/ml, light grey, diamonds) for 48 hours compared to M-CSF 
(50 ng/ml) controls (dark grey, triangles). Bars show mean ± SEM of n=3 biologically 
independent samples. *p=0.0444, **p=0.0013, ****p< 0.0001 (two-way ANOVA, Sidak’s 
MCT). 
h Heatmap of gene expression in cMoP and MC from Cx3cr1
gfp/+
 mice stimulated with LM 
(4 µg/ml) and M-CSF (50 ng/ml) or with M-CSF alone (-) for 48 hours. Shown are standardized 
log2 differences of representative genes for inflammatory response (GO:0006954). Gene array 
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p >0.999 p=0.9576 p=0.9964p=0.9862
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Supplementary Figure 3, related to Figures 4 and 5: Complementary data regarding the 
modification of MGC formation by altering lipid metabolism in cMoP 
a Cholesterol Amplex Red Assay of cMoP  stimulated for 6 days with BCG (MOI 20), heat-fixed 
(hf) BCG (10
6
/ml) or hf M.tb (10 µg/ml) compared to M-CSF control (50 ng/ml).  Cholesterol 
content was normalized to cell number. Bars show mean ± SEM of n=12 biologically 
independent samples in 4 experiments. *p=0.0279, ****p< 0.0001 (ordinary one-way ANOVA, 
Dunnett’s MCT). 
b Representative Hemacolor staining of cMoP from Cx3cr1
gfp/+
 mice stimulated with heat-fixed 
BCG (10
6
/ml) and additionally treated with cholesterol oxidase (2 mU/ml) or PBS (vehicle) for 6 
days. Scale bar: 50 µm. Gamma-correction was adjusted (0.45) in both images. 
c Representative Hemacolor stainings of cMoP from Cx3cr1
gfp/+
 mice stimulated with heat-fixed 
BCG (10
6
/ml) and treated with methyl-β-cyclodextrin (MBCD, 1 mmol), LDL (50 µg/ml) or 
PMA (1 µg/ml) for 6 days. Vehicle control for MBCD was dH2O.  Scale bar: 50 µm. Gamma-
correction was adjusted (0.45) in all images. 
d Analysis of MGC formation of cMoP from Cx3cr1
gfp/+
 mice treated as indicated in 
Supplementary Fig. 3c. Bars show mean ± SEM of n=6 biologically independent samples 
examined over 3 experiments. ***p=0.001, ****p< 0.0001 (one-way ANOVA, Tukey’s MCT). 
e Cell density of  cMoP from Cx3cr1
gfp/+
 mice stimulated with BCG (MOI 20), heat-fixed BCG 
(10
6
/ml) or heat-fixed M.tb (10 µg/ml) and treated with cholesterol oxidase (2 mU/ml, light grey) 
or equal volume of PBS (vehicle, dark grey) for 6 days determined by FACS counting particles. 
Bars show mean ± SEM of n=9 for control, n=5 for BCG (MOI 20), n=7 for hf BCG and n=9 for 
hf M.tb biologically independent samples in 2-4 experiments. ns= not significant, ***p=0.0002, 
****p< 0.0001 (one-way ANOVA, Sidak’s MCT). 
f TNFα production of cMoP from Cx3cr1gfp/+ mice treated as indicated in Supplementary Fig. 3e. 
LPS (100 ng/ml) was added 5 hours prior to analysis. Bars show mean ± SEM of n=5 
independent biological samples examined over 3 experiments. ****p< 0.0001 (one-way 
ANOVA, Sidak’s MCT). 
g cMoP from Cx3cr1
gfp/+
 mice were stimulated with heat-fixed (hf) BCG (10
6
/ml) or hf M.tb 
(10 µg/ml) and treated as indicated in Supplementary Fig. 3c. Cell density was determined by 
FACS counting particles. Bars show mean ± SEM of n=10 for control (M-CSF), n=6 for hf BCG 
and n=5 for hf M.tb biologically independent samples examined over at least 2 experiments. ns= 
not significant, *p< 0.05, **p< 0.01 (one-way ANOVA, Dunnett’s MCT). 
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h Filipin staining of sorted cMoP stimulated with heat-fixed BCG (10
6
/ml) and additionally 
treated with methyl-β-cyclodextrin (MBCD, 1 mmol) by FACS. Depicted is the mean 
fluorescence intensity (MFI) of n=6 biologically independent samples examined over 3 
experiments. 
i TNFα production of cMoP from Cx3cr1gfp/+ mice stimulated with heat-fixed BCG (106/ml) and 
additionally treated with methyl-β-cyclodextrin (MBCD, 1 mmol) or equal volume of dH2O 
(vehicle) for 6 days. LPS (100 ng/ml) was added 5 hours prior to analysis. Bars show mean ± 
SEM of n=5 biologically independent samples in 2 experiments. ****p< 0.0001 (one-way 
ANOVA, Sidak’s MCT). 
j Desmosterol and 7-dehydrocholesterol (7-DHC) content of cMoP (blue) and MC (green) 
relative to cholesterol content from sterol analysis described in Fig. 5e. Depicted are mean ± 
SEM of n=4 independent biological samples (cMoP control with n=3 as one sample could not be 
analyzed for technical reasons). *p=0.0124, **p=0.0033 (desmosterol), **p=0.0085 (7-DHC), 
***p=0.0002 (desmosterol), ***p=0.0002 (7-DHC, cMoP-BCG – MC(-)), ***p=0.001 (7-DHC, 
cMoP(-) – MC-BCG), ****p< 0.0001 (two-way ANOVA, Tukey’s MCT). 
k qRT-PCR analysis of Cyp51, Acat1 and Acat2 mRNA levels relative to Gapdh mRNA of cMoP 
and MC stimulated with heat-fixed BCG (10
6
/ml, diamonds, hatched bars) for 6 days compared 
to M-CSF (50 ng/ml) controls (circles, grey bars). Bars show mean ± SEM of n=5 (Cyp51, Acat1) 
and n=3 (Acat2) biologically independent samples in 2 experiments. *p=0.0354, **p=0.0017 
(Cyp51), **p=0.0093 (Acat1), **p=0.0011 (Acat2, cMoP(-) – cMoP-BCG), **p=0.0022 (Acat2, 


































































































Supplementary Figure 4, related to Figures 4 and 5: Increased glycolysis is relevant for the 
metabolism of multinucleated giant cells
a Glycolysis Stress Test from cMoP stimulated with heat-fixed (hf) BCG (106/ml, dark blue, 
squares) compared to M-CSF (50 ng/ml) control (light blue, circles). Depicted are extracellular 
acidification rate (ECAR) over time and ECAR at indicated time points (1 and 2) in bar graphs. 
Shown are mean ± SEM of n=6 biologically independent samples in 2 experiments. *p=0.0488 
(BCG1 - control2), *p=0.0444 (BCG1 - BCG2), **p=0.0017, ****p< 0.0001 (two-way ANOVA, 
Tukey’s MCT).
b cMoP and MC from Cx3cr1gfp/+ mice were stimulated with BCG (MOI 20) and additionally 
treated with 2-Deoxy-D-glucose (DG; 10 µmol, 20 µmol or 30 µmol) or PBS (vehicle, equal 
volume as used for 30 µmol DG) for 6 days. MGC were quantified by Hemacolor staining. Bars 
show mean ± SEM of n=6 (-) and n=5 (BCG) biologically independent samples. ns= not 
significant (>0.99 for all DG concentrations compared to PBS), **p=0.0017 (10 µmol), 
**p=0.0074 (20 µmol), ****p< 0.0001 (two-way ANOVA, Dunnett’s MCT).
c and d Bone marrow progenitors from Cx3cr1gfp/+ mice were stimulated with LM (4 µg/ml) and 
additionally treated with rapamycin (10 nmol) or DMSO (vehicle, equivalent amount for 10 nmol 
rapamycin) for 6 days. MGC were quantified by Hemacolor staining. Representative pictures are 
shown (scale bar: 50 µm). Bars show mean ± SEM of n=5 independent biological samples (n=4 
for Lin- c-kit+ cells, as one sample was removed for technical reasons). *p=0.0482 (Lin- c-kit+), 
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Supplementary Figure 5, related to Figures 6 and 7: Analysis of the role of CCR2 for 
progenitor recruitment and giant cell formation 
a Comparison of iMoP and MDP cultured for 6 days with heat-fixed (hf) BCG (10
6
/ml) and 
M-CSF (50 ng/ml) or with M-CSF (50 ng/ml) alone (-) with respect to MGC formation and cell 
density. Depicted are mean ± SEM of n=7 (control MGC/cm²), n=5 (BCG MGC/cm²), n=6 
(percentage of total cells and cell density) independent biological samples in at least 2 
experiments. ***p=0.0009 (percentage of total cells), (student´s unpaired t-test, two-tailed); 
***p=0.0007 (cell density), (two-way ANOVA, Tukey’s MCT). 
b Representative FACS dot plots of iMoP frequency in the blood at day 19 after aerosol infection 
with M.tb (200 CFU). Mice were injected i.p. daily with 20 µg of a CCR2 specific antibody 
(MC-21) or isotype control (MC-67) from day 14 to 19. 
c CCR2 (MC-21) staining of bone marrow precursor subsets. 
d Bacterial loads in lung and spleen at day 19 in the infection model described in Supplementary 
Fig. 5b. Depicted are mean ± SD of n=10 mice per group examined over 2 experiments. 
e C57BL/6 (WT) and Ccr2
-/- 
mice were infected with M.tb (100 CFU, strain HN878) via aerosol 
and the lungs analyzed for inflammatory area after 60, 100 and 300 days. Depicted are mean ± 
SEM of n=3 (D60 and Ccr2
-/-
 D100), n=4 (WT D300), n=5 (WT D100, Ccr2
-/-
 D300) mice. 
*p=0.0396 (two-way ANOVA, Tukey’s MCT). 
f Histopathological subclassification of the composition of inflammatory area in WT and Ccr2
-/-
 
mice described in Supplementary Fig. 5e. Bars depict mean ± SEM. 
g Representative H&E-stainings of the lungs from C57BL/6 (WT) and Ccr2
-/- 
mice 60 and 100 
days post infection on which the histopathological analysis described in Supplementary Figs. 5e 
and 5f was based (scale bar: 500 µm). n=3 (D60 and Ccr2
-/-
 D100), n=5 (WT D100) mice 
analyzed.  
h and i Bone marrow progenitors from C57BL/6 and Ccr2
-/-
 mice were stimulated with 
heat-fixed BCG (10
6
/ml) and M-CSF (50 ng/ml) for 6 days. MGC formation was quantified after 
Hemacolor staining (scale bar: 50 µm). Depicted are mean ± SEM of n=3 mice in 1 experiment, 
ns= not significant (p=0.0642 iMoP, p=0.9669 MC), **p=0.0067 (two-way ANOVA, Sidak’s 
MCT). 
j Bacteria per cell measured in cMoP, iMoP and MC in a killing assay approach 4 days post 
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Supplementary Figure 6, related to Figures 8 and 9: Alteration of further immune cell 
subsets in the spleen after infection with M. bovis BCG 
a Representative dot plots of FACS analysis for Ly6C, CD115 and CD11b expression in spleen 
and bone marrow at day 18 and 30 post infection compared to PBS controls in described 
infection model (Fig. 8a). 




 monocytes in spleen, bone marrow and blood at indicated time 
points compared to PBS controls in the described infection model (Fig. 8a) analyzed by flow 
cytometry. Depicted are mean ± SEM of n=11 (control), n=9 (D18) and n=10 (D30) mice 
examined over 8 experiments for spleen and bone marrow and n=10 (control), n=9 (D18) and 
n=8 (D30) mice examined over 7 experiments for blood. ****p< 0.0001 (one-way ANOVA, 
Tukey’s MCT). 
c Quantification of granulocytes, B-cell and T-cell subsets at indicated time points compared to 
PBS controls in the described infection model (Fig. 8a) analyzed by flow cytometry. Depicted are 
mean ± SEM of n=8 (control), n=6 (D18), n=8 (D30) mice examined over 5 experiments. 
*p=0.042 (control – D30), *p=0.0385 (D18 – D30), **p=0.0099, ***p=0.0002 (one-way 
ANOVA, Tukey’s MCT). 
d Overview of immunofluorescence staining of CD68-positive granulomas in the liver (yellow 
dotted line) after described adoptive transfer (Fig. 8g). CD68 staining is shown in white, Hoechst 
staining in blue and BCG-RFP in red. GFP
+
 cells (green) are highlighted with white arrows and 
BCG-RFP with red arrows in the image on the right. Scale bar: 200 µm. Channels were adjusted 






Supplementary Table 1: List of antibodies 
Antibody Conjugate Clone Manufacturer Dilution 
Anti-Ter119 Biotin Ter119 Miltenyi Biotec 1:100 
Anti-CD3e  Biotin 145-2C11 Miltenyi Biotec 1:200 
Anti-CD19  Biotin 6D5 Miltenyi Biotec 1:200 
Anti-SiglecF  Biotin ES22-10D8 Miltenyi Biotec 1:100 
Anti-Sca-1  Biotin D7 Miltenyi Biotec 1:100 





Anti-CD115 PE AFS98 Miltenyi Biotec 1:40 
Anti-CD115 
REAlease 
PE REAL272 Miltenyi Biotec 1:40 
Anti-CD11b VioGreen REA592 Miltenyi Biotec 1:100 
Anti-Ly6G  Biotin 1A8 BioLegend 1:200 
Anti-CD117  Pacific Blue 2B8 BioLegend 1:100 
Anti-CD117  BV 421 2B8 BioLegend 1:100 
Anti-CD115 BV 421 AFS98 BioLegend 1:100 
Anti-F4/80 BV 421 BM8 BioLegend 1:100 
Anti-CD68 AF647 FA-11 BioLegend 1:100 
Anti-CD16/32 purified 93 BioLegend 1:100 
Anti-CD3e APC 145-2C11 BioLegend 1:500 
Isotype Rat 
IgG2a 
BV 421 RTK2758 BioLegend  
Anti-CD4 PerCP-Cy5.5 RM4-5 eBioscience/ 
Thermo Fisher Scientific 
1:800 
Anti-CD45 eFluor 450 30-F11 eBioscience/ 
Thermo Fisher Scientific 
1:200 
Anti-CD45  PerCP Cy5.5 30-F11 eBioscience/ 
Thermo Fisher Scientific 
1:200 
Anti-CD45 FITC 30-F11 eBioscience/ 
Thermo Fisher Scientific 
1:200 
Anti-Ly6C  PerCP Cy5.5 HK1.4 eBioscience/ 




Antibody Conjugate Clone Manufacturer Dilution 
Anti-CD11b  APC-eFluor 
780 
M1/70 eBioscience/ 
Thermo Fisher Scientific 
1:3000 
Anti-F4/80  PE BM8 eBioscience/ 





Thermo Fisher Scientific 
1:100 
Anti-iNOS2 APC CXNFT eBioscience/ 




Anti-iNOS2 PE CXNFT eBioscience/ 










 Thermo Fisher Scientific 1:100 
Streptavidin PE-Cy7  eBioscience/ 
Thermo Fisher Scientific 
1:1000 
Isotype IgG2a, κ PE eBR2a eBioscience/ 
Thermo Fisher Scientific 
 
Anti-Ly6G FITC 1A8 BD bioscience 1:200 
Anti-TNFα APC MP6-XT22 BD bioscience 1:200 
Anti-F4/80 APC Cl:A3-1 Bio-Rad 1:100 





Anti-CCR2 purified MC-21 Matthias Mack 
(Mack et al., 2001. 
Expression and 
characterization of the 
chemokine receptors 
CCR2 and CCR5 in 
mice. J Immunol. 166(7), 
4697-704.) 
in vitro:  
1 µg/100 µl 
in vivo:  
20 µg i.p.  
Isotype control purified MC-67 in vitro: 
1 µg/100 µl 
in vivo:  
20 µg i.p.  
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Supplementary Table 2: Primer sequences for RT-qPCR 
Gene 
Forward (5’ – 3’) Reverse (3’ – 5’) 
Gapdh ACT CCA CTC ACG GCA AAT TC TCT CCA TGG TGG TGA AGA CA 
Abca1 TGG AAA CTC ACC CAG CAA CA GGC AGG ACA ATC TGA GCA AAG 
Abcg1 CCT TCC TCA GCA TCA TGC G CCG ATC CCA ATG TGG A 
Tlr2 TTT GCT GGG CTG ACT TCT CT AAA TCT CCA GCA GGA AAG CA 
Tlr6 CCA AGA ACA AAA GCC CTG AG TGT TTT GCA ACC GAT TGT GT 
Tlr13 ATG TGA AGA CCG TGC CTT TG GGC GGC AGA GAA AAT CCT AC 
Dhcr24 GAG GGC TTG GGA TAC TGC AC CCT TCA CAG GCC AAA TGG ATG 
Fasn GGC TCT ATG GAT TAC CCA AGC CCA GTG TTC GTT CCT CGG A 
proIL-1β TTC AGG CAG GCA GTA TCA CTC GAA GGT CCA CGG GAA AGA CAC 
Kit GCC TGA CGT GCA TTG ATC C AGT GGC CTC GGC TTT TTC C 
Mpo AGG GCC GCT GAT TAT CTA CAT CTC ACG TCC TGA TAG GCA CA 
Msr1 TGG AGG AGA GAA TCG AAA GCA CTG GAC TGA CGA AAT CAA GGA A 
Itgam ATT TTA CCG GAC TGC GTG GA CCC ATG GCA CTC ATG GTG AT 
Adgre1 ACC GTC AGG TAC GGG ATG AA AAC TGC CAT CAA CTC ATG ATA CC 
Sqle ATA AGA AAT GCG GGG ATG TCA C ATA TCC GAG AAG GCA GCG AAC 
Hmgcr AGA GCG AGT GCA TTA GCA AAG GAT TGC CAT TCC ACG AGC TAT 
Acat1 
TGT AAA AGA CGG GCT AAC TGA 
TG 
TGT TCC TGC CGT GAG ATA TTC AT 
Acat2 CCC GTG GTC ATC GTC TCA G GGA CAG GGC ACC ATT GAA GG 











Supplementary Table 3: Number of biologically independent samples (n) for each cell type 
and stimulant for analysis of in vitro MGC formation (Fig. 1f) 





 13 6 5 4 
MDP 13 4 7 4 
cMoP 15 6 7 4 




Supplementary Table 4: Number of biologically independent samples (n) used for each 
stimulant and time point in surface marker expression analysis (Fig. 3a and Supplementary 
Figs. 2a and 2b) 
Stimulus Surface marker 4h 8h 12h 48h 
M-CSF (Supp. Fig. 2a) CD64 3 3 3 3 
M-CSF (Supp. Fig. 2a) CX3CR1 7 9 8 6 
M-CSF (Supp. Fig. 2a) CD115 5 5 3 3 
M-CSF (Supp. Fig. 2a) Ly6C 4 4 4 3 
M-CSF (Fig. 3a) F4/80 4 4 3 5 
M-CSF (Fig. 3a) CD11b 7 9 8 5 
M-CSF (Fig. 3a) CD117 3 4 3 (cMoP),  
4 (MC) 
- 
LM (Supp. Fig. 2b) F4/80 4 4 3 5 
LM (Supp. Fig. 2b) CD11b 7 9 8 5 
LM (Supp. Fig. 2b) CD64 3 3 3 3 









Supplementary Table 5: Number of mice (n) used for each mouse line and time point in 
M.tb aerosol infection (Figs. 6a and 6c) 
 mouse line uninfected Day 7 Day 14 Day 21 
cMoP in BM 
(Fig. 6a) 
C57BL/6 9 5 10 10 
129S2 9 5 10 10 
cMoP in blood 
(Fig. 6a) 
C57BL/6 8 - 9 10 
129S2 9 - 9 10 
iMoP in BM 
(Fig. 6c) 
C57BL/6 9 5 10 10 
129S2 9 4 10 10 
iMoP in blood 
(Fig. 6c) 
C57BL/6 8 - 8 9 




Supplementary Table 6: Number of biologically independent samples (n) for each cell type 
and time point in BCG in vitro infection (Supplementary Fig. 1a) 
 cell type Day 2 Day 4 Day 6 




 3 3 5 
MDP 5 5 7 
cMoP 5 5 7 
MC 5 5 7 




 3 3 4 
MDP 3 3 4 
cMoP 3 3 4 
MC 3 3 4 
 
 
 
 
